Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (331-340 of 388) with videos related to

Pageof 39
Sort By:
Epidemics|June 18, 2026
Measuring the growth of infectious disease modelling publications and their impact on policymaking: A large language model-assisted bibliometric reviewPaula Christen, Malik H A Ahmed, Brandon Wen Bing Chua, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 31, 2021
Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detectionThibaut Jombart, Stéphane Ghozzi, Dirk Schumacher, et al.
Vaccine|November 17, 2019
The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic reviewStephanie L Hughes, Shelly Bolotin, Sumaiya Khan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Health Affairs (Project Hope)|February 6, 2018
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing CountriesAngela Y Chang, Carlos Riumallo-Herl, Nicole A Perales, et al.
BMC Public Health|September 4, 2024
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in KenyaJoyce U Nyiro, Bryan O Nyawanda, Martin Mutunga, et al.
The Lancet. Global Health|June 20, 2020
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling studyAndrew Clark, Mark Jit, Charlotte Warren-Gash, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Vaccine|February 3, 2023
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countriesAbraham M Getaneh, Xiao Li, Zhuxin Mao, et al.
Archives of Disease in Childhood|May 7, 2018
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancerJessica Bate, Stephen Baker, Judith Breuer, et al.
Pageof 39

Showing results (331-340 of 388) with videos related to

Sort By:
Pageof 39
Epidemics|June 18, 2026
Measuring the growth of infectious disease modelling publications and their impact on policymaking: A large language model-assisted bibliometric reviewPaula Christen, Malik H A Ahmed, Brandon Wen Bing Chua, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 31, 2021
Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detectionThibaut Jombart, Stéphane Ghozzi, Dirk Schumacher, et al.
Vaccine|November 17, 2019
The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic reviewStephanie L Hughes, Shelly Bolotin, Sumaiya Khan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Health Affairs (Project Hope)|February 6, 2018
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing CountriesAngela Y Chang, Carlos Riumallo-Herl, Nicole A Perales, et al.
BMC Public Health|September 4, 2024
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in KenyaJoyce U Nyiro, Bryan O Nyawanda, Martin Mutunga, et al.
The Lancet. Global Health|June 20, 2020
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling studyAndrew Clark, Mark Jit, Charlotte Warren-Gash, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Vaccine|February 3, 2023
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countriesAbraham M Getaneh, Xiao Li, Zhuxin Mao, et al.
Archives of Disease in Childhood|May 7, 2018
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancerJessica Bate, Stephen Baker, Judith Breuer, et al.
Pageof 39